Inventor

Paul O. Zamora

Inventor

Gaithersburg, MD, US

Overview

45→

Patents

1995–2021

Patent span

Human necessities

Primary field (CPC A)

Patents· 45 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes26%

C07KPeptides22%

A61LMethods or apparatus for sterilising materials or objects in general15%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations11%

C07HSugars5%

C08LCompositions of macromolecular compounds4%

C09DCoating compositions, e.g. paints, varnishes or lacquers3%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests3%

Y10TTechnical subjects covered by former us classification3%

C08BPolysaccharides2%

PatentTitleYear

11,078,244Composition and method for delivery of BMP-2 amplifler/co-activator for enhancement of osteogenesis2021 10,611,810Positive modulator of bone morphogenic protein-22020 10,246,499Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis2019 10,174,088Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis2019 RE047115Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis2018 9,670,258'Positive modulator of bone morphogenic protein-2'2017 8,796,212'Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis'2014 8,227,411'FGF growth factor analogs'2012 8,163,717'Dual chain synthetic heparin-binding growth factor analogs'2012 8,101,570'Single branch heparin-binding growth factor analogs'2012 7,981,862'Composition comprising BMP-2 amplifier/co-activator for enhancement of osteogenesis'2011 7,820,172'Laminin-derived multi-domain peptides'2010 7,700,563'Synthetic heparin-binding factor analogs'2010 7,671,012'Formulations and methods for delivery of growth factor analogs'2010 7,598,224'Dual chain synthetic heparin-binding growth factor analogs'2009 7,528,105'Heterodimeric chain synthetic heparin-binding growth factor analogs'2009 7,482,427'Positive modulator of bone morphogenic protein-2'2009 7,468,210'Cross-linked heparin coatings and methods'2008 7,414,028'Growth factor analogs'2008 7,297,343'Bioactive medical films'2007 7,217,769'Medical device with plasma cross-linked hydrophilic coating'2007 7,166,574'Synthetic heparin-binding growth factor analogs'2007 6,921,811'Bioactive coating composition and methods'2005 6,765,069'Plasma cross-linked hydrophilic coating'2004 6,685,912'Post-labeling stabilization of radiolabeled proteins and peptides'2004 6,613,432'Plasma-deposited coatings, devices and methods'2003 6,596,699'Nucleic acid coating compositions and methods'2003 6,575,888'Bioabsorbable brachytherapy device'2003 6,342,591'Amphipathic coating for modulating cellular adhesion composition and methods'2002 6,261,536'Post labeling stabilization of radiolabeled proteins and peptides'2001 6,248,057'Absorbable brachytherapy and chemotherapy delivery devices and methods'2001 6,066,309'Post-labeling stabilization of radiolabeled proteins and peptides'2000 5,985,240'Peptide radiopharmaceutical applications'1999 5,861,139'Direct labeling of peptides with metal ions'1999 5,759,515'Polyvalent peptide pharmaceutical applications'1998 5,759,516'Peptide-metal ion pharmaceutical preparation'1998 5,738,838'IKVAV peptide radiopharmaceutical applications'1998 5,718,882'IKVAV peptide radiopharmaceutical applications'1998 5,700,444'Chemotactic peptide pharmaceutical applications'1997 5,690,905'Peptide-metal ion pharmaceutical labeling method'1997 5,670,133'Peptides method for radiolabeling them, and method for detecting inflammation'1997 5,567,408'YIGSR peptide radiopharmaceutical applications'1996 5,556,609'YIGSR peptide radiopharmaceutical applications'1996 5,460,785'Direct labeling of antibodies and other protein with metal ions'1995 5,443,816'Peptide-metal ion pharmaceutical preparation and method'1995

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1995–2004Patents assigned to RHOMED INC (15)· patent assignee history

1995–1999Based in Albuquerque, NM, US· patent location history

1998Based in Bonn, DE· patent location history

1999–2001Based in Guadalajara, MX· patent location history

2001–2021Based in Gaithersburg, MD, US· patent location history

2002–2014Patents assigned to BIOSURFACE ENG TECH INC (21)· patent assignee history

2004Based in Gaithersberg, MD, US· patent location history

2009–2021Patents assigned to BROOKHAVEN SCIENCE ASS LLC (9)· patent assignee history

2012–2020Patents assigned to LIN XINHUA (5)· patent assignee history

2017–2021Patents assigned to FERRING BV (5)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
BIOSURFACE ENG TECH INC	21	2002–2014
RHOMED INC	15	1995–2004
BROOKHAVEN SCIENCE ASS LLC	9	2009–2021
FERRING BV	5	2017–2021
LIN XINHUA	5	2012–2020

Locations

Location	Patents	Span
Gaithersburg, Maryland, US	29	2001–2021
Albuquerque, NM, US	10	1995–1999
Guadalajara, MX	3	1999–2001
Gaithersberg, Maryland, US	1	2004
Bonn, DE	1	1998